Overview

Abcodia creates blood tests that help detect cancer early. Its main product, the ROCA Test, analyzes substances in blood (serum biomarkers) to estimate a woman's risk of having ovarian cancer, offering a non-invasive and affordable screening option. The company relies on a large serum biobank and a business model built around discovering and validating new biomarkers, then turning them into diagnostic tests sold to healthcare providers and partners. By focusing on non-invasive, early detection, Abcodia aims to improve treatment outcomes and survival rates for solid tumors overall.